A former official at the Centers for Disease Control and Prevention warns that funding cuts outlined in the proposed fiscal ...

Increasing the use of Apretude among Black women requires not only expanding awareness of the long-acting PrEP regimen in ...

Congress just passed a sweeping bill that includes changes to Medicaid expected to cut millions of people with low incomes ...

Former CDC officials warn that proposed fiscal 2026 budget cuts would slash funding by 54%, threatening critical health ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

Dozens of HIV experts at the Centers for Disease Control and Prevention received emails earlier in June revoking notices they received 10 weeks ago that laid them off. Damage to their projects may ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

Trump's budget plan would bar clinics that provide abortions — which tend to be testing sites for HIV — from accepting ...

How will the Trump administration's cuts to HIV research impact the progress that's been made towards ending the epidemic in the U.S.?

COVID paused prevention efforts, which helped fuel the rise in new infections. Now federal funding cuts threaten to disrupt those efforts again.

In a sweeping national overhaul of HIV prevention funding, the CDC chose to bypass local and statewide community organizations like AVOL Kentucky.

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV.